BVF INC/IL

Holdings History for MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

Symbol: MLTX on Nasdaq
Investment type: Equity / Class A ordinary share, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	8.8%	0%	$260,321,923	19,751,284	0		$13.18	Q4 2025
30 Sep 2025	5.7%	0%	$141,616,706	19,751,284	0		$7.17	Q3 2025
30 Jun 2025	33%	0%	$932,260,605	19,751,284	0		$47.20	Q2 2025
31 Mar 2025	31%	0%	$771,682,666	19,751,284	0		$39.07	Q1 2025
31 Dec 2024	36%	-3.7%	$1,069,532,029	19,751,284	-2,000,000	-9.2%	$54.15	Q4 2024
30 Sep 2024	32%	0%	$1,096,699,739	21,751,284	0		$50.42	Q3 2024
30 Jun 2024	27%	0%	$956,403,957	21,751,284	0		$43.97	Q2 2024
31 Mar 2024	30%	0%	$1,092,566,995	21,751,284	0		$50.23	Q1 2024
31 Dec 2023	33%	0%	$1,313,560,041	21,751,284	0		$60.39	Q4 2023
30 Sep 2023	33%	0%	$1,239,823,188	21,751,284	0		$57.00	Q3 2023
30 Jun 2023	31%	0%	$1,109,315,484	21,751,284	0		$51.00	Q2 2023
31 Mar 2023	17%	0%	$465,259,965	21,751,284	0		$21.39	Q1 2023
31 Dec 2022	9.6%	0%	$228,388,482	21,751,284	0		$10.50	Q4 2022
30 Sep 2022	7.2%	0%	$173,140,000	21,751,284	0		$7.96	Q3 2022
30 Jun 2022	5.5%	+5.5%	$114,194,000	21,751,284	+21,751,284	NEW	$5.25	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.